3Sweer L, Zwillich CW. Dyspnea in the patient with chronic obstructive pulmonary disease [J]. Clin Chest Med, 1990, 11 (3) :417-425.
4Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance[J]. Thorax, 1984 39(11):818-822.
5Celli BR, Cote CG, Marin JM, et al. The body-mass index, airglow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J]. N Engl J Med, 2004,350(10) :1005-1012.
6Haurani FI. Interpretation of serum ferritin in anemia of chronic disease[J]. Am J Hematol, 2002,69 (4): 296.
8Oren R, Beeri M, Hubert A, et al. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease[J]. Arch Intern Med, 1997,157(13) : 1474-1478.
9Calverley PM, Leggett RJ, McElderry L, et al. Cigarette smoking and secondary polyeythemia in hypoxic cor pulmonale [J]. Am Rev Respir Dis,1982,125(5) :507-510.
1Oguz A,Uzunlulu M, Hekim N. Hepeidin is not a marker of chronic inflammation in atheroselerosis[J]. Anadolu Kardiyol Derg,2006,6(3) :239-242.
2Coussons PJ,Baig S, Fanutti C, et al. Novel tissue remodelling roles for human recombinant erythropoietin[J]. Biochem Soc Trans, 2005, 33(5) : 1129-1130.
3Cavill I,Auerbach M,Bailie GR,et al. Iron and the anaemia of chronic disease: a review and strategic recommendations [J]. Curr Med Res Opin,2006,22(4) :731-737.
4Lowenthal RM, Francis H, Gill DS. Twenty-year remission of rheumatoid arthritis in 2 patients after allogeneic bone marrow transplant[J]. J Rheumatol, 2006,33(4) : 812-813.
5Theurl I, Mattle V, Seifert M, et al. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease[J]. Blood, 2006, 107 (10):4142- 4148.
6Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease[J].N Engl J Med,1996,334(10) :619-623.
8Papadaki HA, Kritikos HD, Gemetzi C, et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect[J]. Blood, 2002,99(5) 1610-1619.
9Liu H,Pope RM. The role of apoptosis in rheumatoid arthritis [J]. Curr Opin Pharmaeol, 200a, 3(3) :317-322.
10Laftah AH, Sharma N, Brookes MJ. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice[J]. Biochem J, 2006,397 (1) : 61-67.
4Yohannes AM, Ershler WB. Anemia in COPD.. a systematic re- view of the prevalence, quality of life, and mortality [J]. Respir Care,2011,56(5) ;644-652.
5Chambellan A,Chailleux E,Similowski T,et al. Prognostic value of the hematocrit in patients with severe COPD receiving long- term oxygen therapy I-J]. Chest,2005,128(9) ~ 1201-1208.
6John M, Hoemig S, Doehner W, et a l. Anemia and inflammation in COPD ~J]. Chest,2005,127(3) :825-829.
7Cote C, Zilberberg MD, Mody SH, et al. Hemoglobin level and its clinical impact in a cohort of patients with COPD EJ~. Eur Re- spir J,2007,29:923-929.
8Similowski T, Agusti A, MaeNee W, et al. The potential impact of anemia of chronic disease in COPD [J~. Eur Respir J, 2006, 27:390-396.
9Guralnik JM, Ershler WB, Schrier SL,et al. Anemia in the eld- erly: a public health crisis in hematology I-J~. Hematology Amer- ican Society of Hematology education program, 2005, 1: 528- 532.
